CA2143523A1 - Vitamin c delivery system - Google Patents
Vitamin c delivery systemInfo
- Publication number
- CA2143523A1 CA2143523A1 CA002143523A CA2143523A CA2143523A1 CA 2143523 A1 CA2143523 A1 CA 2143523A1 CA 002143523 A CA002143523 A CA 002143523A CA 2143523 A CA2143523 A CA 2143523A CA 2143523 A1 CA2143523 A1 CA 2143523A1
- Authority
- CA
- Canada
- Prior art keywords
- cosmetic product
- product according
- weight
- substance
- ascorbic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title claims abstract description 90
- 229960005070 ascorbic acid Drugs 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 87
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 31
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 31
- 239000002537 cosmetic Substances 0.000 claims abstract description 19
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 9
- 239000003937 drug carrier Substances 0.000 claims abstract description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 235000011187 glycerol Nutrition 0.000 claims description 9
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 229920001451 polypropylene glycol Polymers 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 4
- 150000005846 sugar alcohols Polymers 0.000 claims description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 2
- 239000002535 acidifier Substances 0.000 claims description 2
- 150000003973 alkyl amines Chemical class 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- -1 glycol ethers Chemical class 0.000 description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 239000000194 fatty acid Substances 0.000 description 16
- 235000019441 ethanol Nutrition 0.000 description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 13
- 229930003268 Vitamin C Natural products 0.000 description 13
- 235000019154 vitamin C Nutrition 0.000 description 13
- 239000011718 vitamin C Substances 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 239000003755 preservative agent Substances 0.000 description 10
- 239000000969 carrier Substances 0.000 description 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 6
- 229940008099 dimethicone Drugs 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 239000000516 sunscreening agent Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- 230000000475 sunscreen effect Effects 0.000 description 4
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002125 SokalanĀ® Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 2
- 229960004543 anhydrous citric acid Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 229940085262 cetyl dimethicone Drugs 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid Chemical class OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 2
- 229960000655 ensulizole Drugs 0.000 description 2
- 229940088638 glycereth-7 Drugs 0.000 description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 150000003873 salicylate salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- JQJSFAJISYZPER-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(2,3-dihydro-1h-inden-5-ylsulfonyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NS(=O)(=O)C1=CC=C(CCC2)C2=C1 JQJSFAJISYZPER-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical class CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- IOAOAKDONABGPZ-UHFFFAOYSA-N 2-amino-2-ethylpropane-1,3-diol Chemical compound CCC(N)(CO)CO IOAOAKDONABGPZ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HMKKFLSUPRUBOO-IUPFWZBJSA-N 3,4-dihydroxy-5-[3,4,5-tris[[(z)-octadec-9-enoyl]oxy]benzoyl]oxybenzoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC1=C(OC(=O)CCCCCCC\C=C/CCCCCCCC)C(OC(=O)CCCCCCC\C=C/CCCCCCCC)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(O)=O)O)=C1 HMKKFLSUPRUBOO-IUPFWZBJSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical class OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 description 1
- XTQUSEDRZLDHRC-UHFFFAOYSA-N 3-octadecanoyloxybutyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCCCCCCCCCCCC XTQUSEDRZLDHRC-UHFFFAOYSA-N 0.000 description 1
- NZXZINXFUSKTPH-UHFFFAOYSA-N 4-[4-(4-butylcyclohexyl)cyclohexyl]-1,2-difluorobenzene Chemical compound C1CC(CCCC)CCC1C1CCC(C=2C=C(F)C(F)=CC=2)CC1 NZXZINXFUSKTPH-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-M 4-aminobenzoate Chemical class NC1=CC=C(C([O-])=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-M 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- IBYCEACZVUOBIV-UHFFFAOYSA-N 4-methylpentyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCC(C)C IBYCEACZVUOBIV-UHFFFAOYSA-N 0.000 description 1
- AUGIYYGVQDZOLU-UHFFFAOYSA-N 4-methylpentyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCC(C)C AUGIYYGVQDZOLU-UHFFFAOYSA-N 0.000 description 1
- BRORPGSJXSLXKN-UHFFFAOYSA-N 6-methylheptyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCOC(=O)CC(C)CC(C)(C)C BRORPGSJXSLXKN-UHFFFAOYSA-N 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000186892 Aloe vera Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 229920004511 Dow CorningĀ® 200 Fluid Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 229920003091 Methocel⢠Polymers 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- CMCJFUXWBBHIIL-UHFFFAOYSA-N Propylene glycol stearate Chemical class CC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CMCJFUXWBBHIIL-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 229920013820 alkyl cellulose Polymers 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N benzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- PPOZILIWLOFYOG-UHFFFAOYSA-N bis(2-hexyldecyl) hexanedioate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(=O)OCC(CCCCCC)CCCCCCCC PPOZILIWLOFYOG-UHFFFAOYSA-N 0.000 description 1
- IUGNTDSUZLPSOK-UHFFFAOYSA-N bis(4-methylpentyl) hexanedioate Chemical compound CC(C)CCCOC(=O)CCCCC(=O)OCCCC(C)C IUGNTDSUZLPSOK-UHFFFAOYSA-N 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- NZIKRHKSEITLPS-UHFFFAOYSA-N butane-1,3-diol;octadecanoic acid Chemical compound CC(O)CCO.CCCCCCCCCCCCCCCCCC(O)=O NZIKRHKSEITLPS-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000007073 chemical hydrolysis Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001893 coumarin derivatives Chemical class 0.000 description 1
- KBODESQIOVVMAI-UHFFFAOYSA-N decyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCC KBODESQIOVVMAI-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical class CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1
- 229960002248 meradimate Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001921 poly-methyl-phenyl-siloxane Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical class [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/882—Mixing prior to application
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
A cosmetic product formed as a multi-compartment dispenser is provided wherein an aqueous and an anhydrous composition are stored in separate compartments. The anhydrous composition includes ascorbic acid delivered in a pharmaceutically acceptable carrier. The aqueous composition includes an alkaline agent present to cause a rise in pH of the anhydrous composition as both compositions are blended together after being dispensed from their respective compartments.
Description
-- 214~523 GUERRERO ET AL. 92-0310-EA ~\~Z
VITAMIN C DELIVERY SYSTEM
BACKGROUND OF THE INVENTION
Field of the Invention The invention relates to a cosmetic product that can stably store ascorbic acid and then deliver same to the skin.
The Related Art Ascorbic acid, also known by its common name of Vitamin C, has long been recognized as an active substance benefiting skin appearance. Vitamin C reportedly increases the production of collagen in human skin tissue. Wrinkles and fine lines are thereby reduced. An overall healthier and younger-looking appearance results.
Vitamin C has also found utility as an ultraviolet ray blocking or absorbing agent.
Whitening or bleaching skin compositions have also employed Vitamin C utilizing its property of interference with the melanin formation process. There also is a belief that ascorbic acid interacts with the human immune system to reduce sensitivity to skin-aggravating chemicals. Reduced levels of Vitamin C concentration on the skin have also been implicated with an increase in stress. From all of the foregoing perspectives, Vitamin C or ascorbic acid may provide significant benefit when topically . _ GUERRERO ET AL. 92~31 0-EA
applied.
Unfortunately, Vitamin C is a very unstable substance. Although it is readily soluble in water, rapid oxidation occurs in aqueous media. Solubility of ascorbic acid has been reported to be relatively poor in nonaqueous media, thereby preventing an anhydrous system from achieving any significant level of active concel,tration.
The art has sought to overcome the problem in a variety of ways. One approach is the preparation of ascorbic acid derivatives. These derivatives have greater stability than the parent compound and, through biotransformation or chemical hydrolysis, can at the point of use be converted to the parent acid. For instance, U.S.
Patent 5,137,723 (Yamamoto et al) and U.S. Patent 5,078,989 (Ando et al) provide glycosylate and ester derivatives, respectively.
U.S. Patent 4,818,521 (Tamabuchi) describes under the background technology a so-called two-pack type cosmetic wherein Vitamin C powder and other ingredients are separately packaged in different containers with mixing just prior to use of the cosmetic. The mixing procedure and expensive packaging were said to be drawbacks of this system. The patent suggests stable oil-in-water type emulsions that are weakly acidic and wherein ascorbic acid has been premixed with a stabilizing oil.
` 2143523 _.
GUERRERO ET AL. 92-031 0-EA
Maintenance of pH below about 3.5 has also been suggested in U.S.
Patent 5,140,043 (Darr et al) as a stabilization means for aqueous compositions of ascorbic acid.
Water compatible alcohols such as propylene glycol, polypropylene glycol and glycerol have been suggested as co-carriers alongside water to improve stability. An illustration of this approach can be found in U.S. Patent 4,983,382 (Wilmott and Znaiden). Therein a blend of water and water-miscible organic solvent are combined as a stabilizing system. At least about 40% of the organic solvent must be ethanol while the remainder may be selected from such alcohols as propylene glycol, glycerin, dipropylene glycol and polypropylene glycol.
U.S. Patent 4,372,874 (Modrovich) has reported incorporation of relatively large amounts of ascorbic acid in a polar water-miscible organic solvent such as dimethyl sulfoxide. Levels of water are kept below 0.5% through addition of a particulate desiccant to the carrier. Although highly polar systems such as dimethyl sulfoxide may be effective, this and related carriers are toxicologically questionable.
Accordingly, it is an object of the present invention to provide a delivery system for ascorbic acid in which the compound is storage stable.
214~523 ~.
GUERRERO ET AL. 92-0310-EA
Another object of the present invention is to provide a deliver,v system which delivers ascorbic acid at a pH,compatible with that of human skin to avoid irritation and obtain better penetration.
Still another object of the present invention is to provide a system for delivering ascorbic acid that is sufficiently transparent so as to render the system aesthetically - pleasing.
A still further object of the present invention is to provide a system for delivering ascorbic acid to the skin that includes a carrier which is at least half water.
These and other objects of the present invention will become more readily apparent through the following summary, detailed discussion and Examples.
GUERRERO ET AL. 92-0310-EA
SUMMARY OF THE INVENTION
A cosmetic product is provided which is formed as a multi-compartment dispenser, wherein a first and second substance are stored apart from one another in separate compartments of the dispenser:
(i) the first substance being an anhydrous composition comprising from:
a) from 0.001 to 50% by weight of ascorbic acid; and b) from 0.01 to 99% by weight of a pharmaceutically acceptable carrier;
and (ii) the second substance being an aqueous composition comprising an alkaline agent present in an effective amount to cause a rise in pH of thefirst substance when blended therewith.
DETAILED DESCRIPTION OF THE INVENTION
Now it has been discovered that a multi-compartment dispenser can be utilized for stably retaining under storage an anhydrous ascorbic acid-containing composition.
A separate second compartment may be utilized to store an aqueous composition whose components over time would ordinarily adversely interact with the ascorbic acid to decrease the ascorbic acid activity. Especially present in the aqueous composition will be an alkaline agent capable of producing a rise in pH of the anhydrous composition when blended together just prior to use. In this manner, a relatively more alkaline final blended composition can be delivered to the skin whose acidity is insufficient to cause skin irritation but, nevertheless, delivers active ascorbic acid.
Thus, one essential element of the present invention is an anhydrous composition that includes ascorbic acid. The amount of ascorbic acid should range from about 0.001 to about 50%, preferably from about 0.01 to about 10%, optimally between about 3 and 6% by weight of the anhydrous composition.
A wide variety of vehicles or carriers can be utilized to deliver the ascorbic acid.
The carrier must be inert to the active substance. Usually the carrier is an ingredient present in highest amounts and generally can range from about 5 to about 99.9%, GUERRERO ET AL. 92-0310-EA
preferably from about 25 to about 90%, optimally between about 70 and 85% by weight of the anhydrous composition.
Illustrative of the carriers for the anhydrous composition of this invention are glycerin, polyethylene glycols, polypropylene glycols, ethylene oxide/propylene oxide copolymers, alkoxylated polysaccharides, alkoxylated glycerin and monoalkyl glycol ethers.
These carriers are distinguished by their miscibility with water and having at least one free hydroxyl group. Among the preferred carriers are glycerin, glycereth-7, polyethylene glycol (M.W. 400), polyglycerols and diethylene glycol monoethyl ether.
The aforementioned class of carriers has been found to stabilize ascorbic acid.
Lower alcohols such as ethyl alcohol may be present to assist the carrier.
However, it is best to keep the concentration of lower alcohol at no higher than 20%, preferably ranging from 0.1 to about 10% by weight.
Esters are another category of suitable carrier. Among esters that may be utilized are:
~1~3523 `
(1) Alkyl esters of fatty acids having 10 to 20 carbon atoms. Methyl, isopropyl, and butyl esters of fatty acids are useful herein. Examples include hexyl laurate, isohexyl laurate, isohexyl palmitate, isopropyl palmitate, decyl oleate, isodecyl oleate, hexadecyl stearate, decyl stearate, isopropyl isostearate, diisopropyl adipate, diisohexyl adipate, dihexyldecyl adipate, diisopropyl sebacate, isononyl isononanoate, isodecyl isononanoate, lauryl lactate, myristyl lactate, and cetyl lactate. Particularly preferred are C12-C1s alcohol benzoate esters.
- (2) Alkenyl esters of fatty acids having 10 to 20 carbon atoms. Examples thereof include oleyl myristate, oleyl stearate, and oleyl oleate.
(3) Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.
(4) Polyhydric alcohol esters. Ethylene glycol mono and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono-and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl monostearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters.
21~S23 GUERRER0 ET AL. 92-031 0-EA
(5) Wax esters such as beeswax, spermaceti, myristyl myristate, stearyl stearate.
(6) Sterols esters, of which cholesterol fatty acid esters are examples thereof.
Emulsifiers may also be present in the compositions of this invention. These emulsifiers may either be anionic, nonionic, cationic or amphoteric type. Nonionic emulsifiers are particularly preferred, especially polyoxyalkylene polyol fatty acid esters (which may also operate as ester emollients). Most preferred is polyethylene oxide (15) trimethylolpropane isostearate. Levels of emulsifier may range anywhere from about 0.1 to about 20%, preferably between about 1 and 5% by weight.
Silicone oils may also be used as carriers. These oils may be either volatile or nonvolatile. The term Uvolatile'' as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic or linear polydimethylsiloxanes containing from about 3 to about 9, preferably from about 4 to about 5, silicon atoms.
Linear volatile silicone materials generally have viscosities less than about 5 centistokes at 25C while cyclic materials typically have viscosities of less than about 1 0 centistokes.
~ .
GUERRERO ET AL. 92-0310-EA
Examples of preferred volatile silicone oils useful herein include: Dow Corning 344, Dow Corning 345 and Dow Corning 200 (manufactured by Dow Corning Corp.);
Silicone 7207 and Silicone 7158 (manufactured by the Union Carbide Corp.); SF 1202 (manufactured by General Electric); and SWS-03314 (manufactured by SWS
Silicones, Inc.).
The nonvolatile silicone oils useful in compositions of this invention are exemplified by the polyalkyl siloxanes, polyalklyaryl siloxanes and polyether siloxane copolymers. The essentially nonvolatile polyalkyl siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from about 5 to about 100,000 centistokes at 25C. Among the preferred nonvolatile silicones useful in the present compositions are the polydimethyl siloxanes having viscosities from about 10 to about 400 centistokes at 25C. Such polyalkyl siloxanes include the Viscasil series (sold by General Electric Company) and the Dow Corning 200 series (sold by Dow Corning Corporation). Polyalkylaryl siloxanes include poly(methylphenyl)siloxanes having viscosities of from about 15 to about 65 centistokes at 25C. These are available, for example, as SF 1075 methylphenyl fluid (sold by General Electric Company) and 556 Cosmetic Grade Fluid (sold by Dow Corning Corporation). Useful polyether siloxane copolymers include, for example, a polyoxyalkylene ether copolymer having a viscosity of about 1200 to 1500 centistokes at 25C. Such a fluid is available as SF-1066 ` .
GUERRERO ET AL. 92-0310-EA
organosilicone surfactant (sold by General Electric Company). Cetyl dimethicone copolyol, cetyl dimethicone and dimethicone copolyol are especially preferred because these materials also function as emulsifiers and emollients.
Among other skin benefit agents which may be present in the anhydrous compositions of this invention are fatty acids having from 10 to 20 carbon atoms.
Suitable examples of the fatty acids include pelargonic, lauric, myristic, palmitic, stearic, isostearic, hydroxystearic, oleic, linoleic, ricinoleic, arachidic, behenic, and erucic acids. These materials may be present in amounts anywhere from about 0.1 to about 20%. preferably between about 2 and 10% by weight of the anhydrous composition.
Acidifying agents may also be included in the anhydrous composition. These may be either organic or inorganic and range in amount from about 0.1 to about 20%, preferably between about 1 and 10%, optimally between about 2 and 6% by weight.
The acids may include alginic acid, citric acid, malic acid, succinic acid, lactic acid, glycolic acid, tartaric acid, sorbic acid, phosphoric acid, acid phosphate salt, acid pyrophophate salt, bitartrate salt and metal acid citrate.
GUERRERO ET AL. 92 0310-EA
According to the present invention there is also required a separate second substance which is an aqueous composition containing an alkaline material for increasing pH when blended with the nonaqueous composition. The rise in pH should be at least 0.5 units, preferably at least 1.0 units and optimally at least 2 units on the pH acidity scale. Ordinarily the pH of the first substance will range from about 1 to about 4, preferably from about 2 to about 3.6. The second substance will have a pH
ranging from about 7 to about 11, preferably from about 8 to about 9. When the first and second substances are combined, the blend should have a pH ranging from about 4.5 to about 6.5.
Among the most suitable alkaline materials are the bicarbonate salts, especially sodium and potassium bicarbonates. These may be present in the aqueous composition in an amount from about 1 to about 30%, preferably from about 1.5 to about 10%, optimally between about 2 and 5% by weight of the aqueous composition.
Alkaline materials stronger than bicarbonate may also be present. These include ammonia, alkylamines, hydroxyalkylamines and alkanolamines. Examples of these are triethylamine, triethanolamine, diethanolamine, tetra(hydroxypropyl) diamine, 2-amino-2-methylpropan-1-ol, 2-amino-2-ethyl-1,3-propanediol and 2-amino-2-hydroxymethyl-1,3-propanediol. Levels of the organic alkaline subslance `
GUERRERO ET AL. 92-031 0-EA
may range from about 0.1 to 10%, preferably from about 0.5 to about 5%, optimally between about 0.8 and 1.5% by weight of the aqueous composition.
As a carrier, the aqueous composition will of course include a major amount of water. This amount may range from about 40% to about 99%, preferably between about 60 and about 95%, optimally between about 80 and 85% by weight of the aqueous composition.
Supplemental carriers may include monohydric and polyhydric alcohols ranging in amounts about 1 to about 30%, especially from about 3 and 20%, optimally between about 4 and 15% by weight of the aqueous composition. Especially preferred are ethanol, isopropanol, ethylene glycol, propylene glycol and butylene glycol.
Thickeners or viscosifiers may be present in amounts up to about 10% by weight. As known to those skilled in the art, the precise amount of thickeners can vary depending upon the desired consistency and thickness of the composition.
Exemplary thickeners are xanthan gum, sodium carboxymethyl cellulose, hydroxyalkyl and alkyl celluloses, and cross-linked acrylic acid polymers such as those sold by B.F.
Goodrich under the Carbopol trademark. Most preferred is methyl cellulose and hydroxypropyl methyl cellulose at levels from 0.1 to 5%, preferably from about 0.2 to GUERRERO ET AL. 92-0310-EA
1%, optimally about 0.5% by weight of the aqueous composition.
Preservatives can desirably be incorporated into the cosmetic compositions of this invention to protect against the growth of potentially harmful microorganisms.
While it is in the aqueous phase that microorganisms tend to grow, microorganisms can also reside in the anhydrous or oil phase. As such-, preservatives which have solubility in both water and oil are preferably employed in the present compositions.
Suitable traditional preservatives for compositions of this invention are alkyl esters of parahydroxybenzoic acid. Other preservatives which have more recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds. Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability. Particularly preferred preservatives are methylparaben, imidazolidinyl urea, sodium dehydroacetate, propylparaben, trisodium ethylenediamine tetraacetate (EDTA) and benzyl alcohol. The preservative should be selected having regard for possible incompatibilities between the preservative and other ingredients.
Preservatives are preferably employed in amounts ranging from about 0.01% to about 2% by weight of the composition.
Minor adjunct ingredients may also include fragrances, antifoam agents, 2143S2~
GUERRERO ET AL. 92-031 0-EA
opacifiers (e.g. titanium dioxide) and colorants, each in their effective amounts to accomplish their respective functions. Particularly useful minor ingredients are vitamin E linoleate, sodium hyaluronate and aloe vera gel, as well as other botanicals.
A sunscreen agent is a further desirable ingredient of the compositions of this invention. This ingredient is preferably incorporated into the aqueous composition.
The term Hsunscreen agent" as used herein defines ultraviolet ray-blocking compounds exhibiting absorption within the wavelength region between 290 and 400 nm.
Sunscreens may be classified into five groups based upon their chemical structure:
para-amino benzoates; salicylates; cinnamates; benzophenones; and miscellaneous chemicals including menthyl anthranilate and digalloyl trioleate. Inorganic sunscreens may also be used including titanium dioxide, zinc oxide, iron oxide and polymer particles such as those of polyethylene, polymethylmethacrylates and polyamides.
Preferred materials include p-aminobenzoic acid and its derivatives, anthranilates;
salicylates; cinnamates; coumarin derivatives; azoles; and tannic acid and its derivatives.
According to the present invention there is required a multi-compartment dispenser. Illustrative of such dispensers are those disclosed in U.S. Patents 1,639,699 and 1,699,532, each to Hopkins, describing double collapsible tubes.
` 2143523 GUERRERO ET AL. 92~310-EA
Separation of reactive components is also described in U.S. Patent 4,211,341 (Weyn). Other examples are those found in U.S. Patent 4,487,757 (Kiozpeoplou) under Fig. 1 as well as U.S. Patent 4,528,180, U.S Patent 4,687,663 and U.S. Patent 4,849,213, each of which is to Schaeffer.
The term ~multi-compartmentU may also include separation by means of encapsulation. Thus, the aqueous composition may contain microcapsules surrounding the ascorbic acid composition, the capsule walls serving as a separating compartment. Release of ascorbic acid occurs by crushing of the capsule walls as the product is rubbed onto the skin.
For purposes of this invention, the weight ratio of the aqueous to nonaqueous composition may range from about 10:1 to 1:10, preferably 2:1 to 1:2, optimally about 1:1.
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise indicated.
21~3523 GUERRERO ET AL. 92-0310-EA
An aqueous and an anhydrous composition were prepared according to the formulations set forth below. Each of the compositions were then charged to a respective separate compartment of a dual compartment dispensing apparatus. Each of the compositions had the following components:
COMPOSITION A
Aqueous CompositionWt. %
Deionized Water 83.0 Ethyl Alcohol 7.5 Butylene Glycol 5.0 Sodium Bicarbonate 3.0 Triethanolamine 1.0 Methocel 40-101 (Hydroxypropylmethyl cellulose) 0.5 -GUERRERO ET AL. 92-031 0-EA
COMPOSITION B
Anhydrous Composition Wt. %
Carbowax 400 (polyethylene glycol) 84.0 Ascorbic Acid (Vitamin C) 5.0 Ethyl Alcohol 5.0 Anhydrous Citric Acid 3.0 Isostearic Acid 3.0 21~3~23 GUERRERO ET AL. 92-0310-EA
An aqueous and an anhydrous composition according to the present invention are set forth below. Each of the compositions is charged to a respective separate compartment of a dual-compartment dispensing apparatus. The compositions includethe following components:
COMPOSITION A
Aqueous Composition Wt. %
Deionized Water 77.0 Ethyl Alcohol 8.0 Butylene Glycol 6.0 Triethanolamine 4.0 Dimethicone Copolyol 4.0 Eusolex 232 (sunscreen) 0.5 Methyl Cellulose 0.5 21435~3 -GUERRERO ET AL. 92-031 0-EA
COMPOSITION B
Anhydrous Composition Wt. %
Glycerin 82.0 Ascorbic Acid (Vitamin C) 5.0 Ethyl Alcohol 5.0 Anhydrous Glycolic Acid 3.0 Isostearic Acid 3.0 Dimethicone 2.0 GUERRERO ET AL. 92-0310-EA
An aqueous and an anhydrous composition according to the present invention are set forth below. Each of the compositions is charged to a respective separate compartment of a dual-compartment dispensing apparatus. The compositions include the following components:
COMPOSITION A
Aqueous Composition Wt. %
Deionized Water 83.7 Propylene Glycol 8.0 Isopropanol 3.0 2-Amino-2-methylpropan-1-ol 3.0 Dimethicone Copolyol 2.0 Hydroxypropyl Methyl Cellulose 0.3 ` 2143S23 -GUERRERO ET AL. 92-031 0-EA
COMPOSITION B
Anhydrous Composition Wt. %
Glycereth-7 83.0 Ascorbic Acid (Vitamin C) 5.0 Glycerin 5.0 Anhydrous Lactic Acid 3.0 Linolenic Acid 2.0 Dimethicone Copolyol 2.0 2143~23 GUERRERO ET AL. 92-031 0-EA
An aqueous and an anhydrous composition according to the present invention is set forth below. Each of the compositions is charged to a respective separate compartment of a dual-compartment dispensing apparatus. The compositions include the following components:
COMPOSITION A
Aqueous Composition ' Wt. %
Deionized Water 80.7 Propylene Glycol 8.0 Ethyl Alcohol 6.5 Triethanolamine 4.0 Eusolex 232 (sunscreen) 0.5 Sodium Carboxymethyl Cellulose 0.3 21~352~
' GUERRERO ET AL. 92-031 0-EA
COMPOSITION B
Anhydrous Composition Wt,%
Diethylene Glycol Monoethyl Ether 76.0 Ascorbic Acid (Vitamin C) 10.0 Ethyl Alcohol 5.0 Anhydrous Malic Acid 3.0 Oleic Acid 3.0 Polyoxyethylene 15 Trimethylolpropane Isostearate 3.0 GUERRERO ET AL. 92-031 0-EA
An aqueous and an anhydrous composition according to the present invention are set forth below. Each of the compositions is charged to a respective separate compartment of a dual-compartment dispensing apparatus. The compositions include the following components:
COMPOSITION A
Aqueous Composition ~ Wt. %
Deionized Water 83.0 Ethyl Alcohol 5.0 Butylene Glycol 5.0 Ammonium Hydroxide 4.0 Dimethicone Copolyol 2.5 Methyl Cellulose 0.5 214352~
-GUERRERO ET AL. 92-0310-EA
COMPOSITION B
Anhydrous Composition Wt.%
Carbowax 400 80.9 Isostearic Acid 7.0 Ascorbic Acid (Vitamin C) 5.0 Ethyl Alcohol 5.0 Polyoxyethylene 15 Trimethylolpropane Isostearate 2.0 Anhydrous Citric Acid 0.1 The foregoing description and examples illustrate selected embodiments of the present invention and in light thereof variations and modifications will be suggested to one skilled in the art, all of which are in the spirit and purview of this invention.
VITAMIN C DELIVERY SYSTEM
BACKGROUND OF THE INVENTION
Field of the Invention The invention relates to a cosmetic product that can stably store ascorbic acid and then deliver same to the skin.
The Related Art Ascorbic acid, also known by its common name of Vitamin C, has long been recognized as an active substance benefiting skin appearance. Vitamin C reportedly increases the production of collagen in human skin tissue. Wrinkles and fine lines are thereby reduced. An overall healthier and younger-looking appearance results.
Vitamin C has also found utility as an ultraviolet ray blocking or absorbing agent.
Whitening or bleaching skin compositions have also employed Vitamin C utilizing its property of interference with the melanin formation process. There also is a belief that ascorbic acid interacts with the human immune system to reduce sensitivity to skin-aggravating chemicals. Reduced levels of Vitamin C concentration on the skin have also been implicated with an increase in stress. From all of the foregoing perspectives, Vitamin C or ascorbic acid may provide significant benefit when topically . _ GUERRERO ET AL. 92~31 0-EA
applied.
Unfortunately, Vitamin C is a very unstable substance. Although it is readily soluble in water, rapid oxidation occurs in aqueous media. Solubility of ascorbic acid has been reported to be relatively poor in nonaqueous media, thereby preventing an anhydrous system from achieving any significant level of active concel,tration.
The art has sought to overcome the problem in a variety of ways. One approach is the preparation of ascorbic acid derivatives. These derivatives have greater stability than the parent compound and, through biotransformation or chemical hydrolysis, can at the point of use be converted to the parent acid. For instance, U.S.
Patent 5,137,723 (Yamamoto et al) and U.S. Patent 5,078,989 (Ando et al) provide glycosylate and ester derivatives, respectively.
U.S. Patent 4,818,521 (Tamabuchi) describes under the background technology a so-called two-pack type cosmetic wherein Vitamin C powder and other ingredients are separately packaged in different containers with mixing just prior to use of the cosmetic. The mixing procedure and expensive packaging were said to be drawbacks of this system. The patent suggests stable oil-in-water type emulsions that are weakly acidic and wherein ascorbic acid has been premixed with a stabilizing oil.
` 2143523 _.
GUERRERO ET AL. 92-031 0-EA
Maintenance of pH below about 3.5 has also been suggested in U.S.
Patent 5,140,043 (Darr et al) as a stabilization means for aqueous compositions of ascorbic acid.
Water compatible alcohols such as propylene glycol, polypropylene glycol and glycerol have been suggested as co-carriers alongside water to improve stability. An illustration of this approach can be found in U.S. Patent 4,983,382 (Wilmott and Znaiden). Therein a blend of water and water-miscible organic solvent are combined as a stabilizing system. At least about 40% of the organic solvent must be ethanol while the remainder may be selected from such alcohols as propylene glycol, glycerin, dipropylene glycol and polypropylene glycol.
U.S. Patent 4,372,874 (Modrovich) has reported incorporation of relatively large amounts of ascorbic acid in a polar water-miscible organic solvent such as dimethyl sulfoxide. Levels of water are kept below 0.5% through addition of a particulate desiccant to the carrier. Although highly polar systems such as dimethyl sulfoxide may be effective, this and related carriers are toxicologically questionable.
Accordingly, it is an object of the present invention to provide a delivery system for ascorbic acid in which the compound is storage stable.
214~523 ~.
GUERRERO ET AL. 92-0310-EA
Another object of the present invention is to provide a deliver,v system which delivers ascorbic acid at a pH,compatible with that of human skin to avoid irritation and obtain better penetration.
Still another object of the present invention is to provide a system for delivering ascorbic acid that is sufficiently transparent so as to render the system aesthetically - pleasing.
A still further object of the present invention is to provide a system for delivering ascorbic acid to the skin that includes a carrier which is at least half water.
These and other objects of the present invention will become more readily apparent through the following summary, detailed discussion and Examples.
GUERRERO ET AL. 92-0310-EA
SUMMARY OF THE INVENTION
A cosmetic product is provided which is formed as a multi-compartment dispenser, wherein a first and second substance are stored apart from one another in separate compartments of the dispenser:
(i) the first substance being an anhydrous composition comprising from:
a) from 0.001 to 50% by weight of ascorbic acid; and b) from 0.01 to 99% by weight of a pharmaceutically acceptable carrier;
and (ii) the second substance being an aqueous composition comprising an alkaline agent present in an effective amount to cause a rise in pH of thefirst substance when blended therewith.
DETAILED DESCRIPTION OF THE INVENTION
Now it has been discovered that a multi-compartment dispenser can be utilized for stably retaining under storage an anhydrous ascorbic acid-containing composition.
A separate second compartment may be utilized to store an aqueous composition whose components over time would ordinarily adversely interact with the ascorbic acid to decrease the ascorbic acid activity. Especially present in the aqueous composition will be an alkaline agent capable of producing a rise in pH of the anhydrous composition when blended together just prior to use. In this manner, a relatively more alkaline final blended composition can be delivered to the skin whose acidity is insufficient to cause skin irritation but, nevertheless, delivers active ascorbic acid.
Thus, one essential element of the present invention is an anhydrous composition that includes ascorbic acid. The amount of ascorbic acid should range from about 0.001 to about 50%, preferably from about 0.01 to about 10%, optimally between about 3 and 6% by weight of the anhydrous composition.
A wide variety of vehicles or carriers can be utilized to deliver the ascorbic acid.
The carrier must be inert to the active substance. Usually the carrier is an ingredient present in highest amounts and generally can range from about 5 to about 99.9%, GUERRERO ET AL. 92-0310-EA
preferably from about 25 to about 90%, optimally between about 70 and 85% by weight of the anhydrous composition.
Illustrative of the carriers for the anhydrous composition of this invention are glycerin, polyethylene glycols, polypropylene glycols, ethylene oxide/propylene oxide copolymers, alkoxylated polysaccharides, alkoxylated glycerin and monoalkyl glycol ethers.
These carriers are distinguished by their miscibility with water and having at least one free hydroxyl group. Among the preferred carriers are glycerin, glycereth-7, polyethylene glycol (M.W. 400), polyglycerols and diethylene glycol monoethyl ether.
The aforementioned class of carriers has been found to stabilize ascorbic acid.
Lower alcohols such as ethyl alcohol may be present to assist the carrier.
However, it is best to keep the concentration of lower alcohol at no higher than 20%, preferably ranging from 0.1 to about 10% by weight.
Esters are another category of suitable carrier. Among esters that may be utilized are:
~1~3523 `
(1) Alkyl esters of fatty acids having 10 to 20 carbon atoms. Methyl, isopropyl, and butyl esters of fatty acids are useful herein. Examples include hexyl laurate, isohexyl laurate, isohexyl palmitate, isopropyl palmitate, decyl oleate, isodecyl oleate, hexadecyl stearate, decyl stearate, isopropyl isostearate, diisopropyl adipate, diisohexyl adipate, dihexyldecyl adipate, diisopropyl sebacate, isononyl isononanoate, isodecyl isononanoate, lauryl lactate, myristyl lactate, and cetyl lactate. Particularly preferred are C12-C1s alcohol benzoate esters.
- (2) Alkenyl esters of fatty acids having 10 to 20 carbon atoms. Examples thereof include oleyl myristate, oleyl stearate, and oleyl oleate.
(3) Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.
(4) Polyhydric alcohol esters. Ethylene glycol mono and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono-and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl monostearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters.
21~S23 GUERRER0 ET AL. 92-031 0-EA
(5) Wax esters such as beeswax, spermaceti, myristyl myristate, stearyl stearate.
(6) Sterols esters, of which cholesterol fatty acid esters are examples thereof.
Emulsifiers may also be present in the compositions of this invention. These emulsifiers may either be anionic, nonionic, cationic or amphoteric type. Nonionic emulsifiers are particularly preferred, especially polyoxyalkylene polyol fatty acid esters (which may also operate as ester emollients). Most preferred is polyethylene oxide (15) trimethylolpropane isostearate. Levels of emulsifier may range anywhere from about 0.1 to about 20%, preferably between about 1 and 5% by weight.
Silicone oils may also be used as carriers. These oils may be either volatile or nonvolatile. The term Uvolatile'' as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic or linear polydimethylsiloxanes containing from about 3 to about 9, preferably from about 4 to about 5, silicon atoms.
Linear volatile silicone materials generally have viscosities less than about 5 centistokes at 25C while cyclic materials typically have viscosities of less than about 1 0 centistokes.
~ .
GUERRERO ET AL. 92-0310-EA
Examples of preferred volatile silicone oils useful herein include: Dow Corning 344, Dow Corning 345 and Dow Corning 200 (manufactured by Dow Corning Corp.);
Silicone 7207 and Silicone 7158 (manufactured by the Union Carbide Corp.); SF 1202 (manufactured by General Electric); and SWS-03314 (manufactured by SWS
Silicones, Inc.).
The nonvolatile silicone oils useful in compositions of this invention are exemplified by the polyalkyl siloxanes, polyalklyaryl siloxanes and polyether siloxane copolymers. The essentially nonvolatile polyalkyl siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from about 5 to about 100,000 centistokes at 25C. Among the preferred nonvolatile silicones useful in the present compositions are the polydimethyl siloxanes having viscosities from about 10 to about 400 centistokes at 25C. Such polyalkyl siloxanes include the Viscasil series (sold by General Electric Company) and the Dow Corning 200 series (sold by Dow Corning Corporation). Polyalkylaryl siloxanes include poly(methylphenyl)siloxanes having viscosities of from about 15 to about 65 centistokes at 25C. These are available, for example, as SF 1075 methylphenyl fluid (sold by General Electric Company) and 556 Cosmetic Grade Fluid (sold by Dow Corning Corporation). Useful polyether siloxane copolymers include, for example, a polyoxyalkylene ether copolymer having a viscosity of about 1200 to 1500 centistokes at 25C. Such a fluid is available as SF-1066 ` .
GUERRERO ET AL. 92-0310-EA
organosilicone surfactant (sold by General Electric Company). Cetyl dimethicone copolyol, cetyl dimethicone and dimethicone copolyol are especially preferred because these materials also function as emulsifiers and emollients.
Among other skin benefit agents which may be present in the anhydrous compositions of this invention are fatty acids having from 10 to 20 carbon atoms.
Suitable examples of the fatty acids include pelargonic, lauric, myristic, palmitic, stearic, isostearic, hydroxystearic, oleic, linoleic, ricinoleic, arachidic, behenic, and erucic acids. These materials may be present in amounts anywhere from about 0.1 to about 20%. preferably between about 2 and 10% by weight of the anhydrous composition.
Acidifying agents may also be included in the anhydrous composition. These may be either organic or inorganic and range in amount from about 0.1 to about 20%, preferably between about 1 and 10%, optimally between about 2 and 6% by weight.
The acids may include alginic acid, citric acid, malic acid, succinic acid, lactic acid, glycolic acid, tartaric acid, sorbic acid, phosphoric acid, acid phosphate salt, acid pyrophophate salt, bitartrate salt and metal acid citrate.
GUERRERO ET AL. 92 0310-EA
According to the present invention there is also required a separate second substance which is an aqueous composition containing an alkaline material for increasing pH when blended with the nonaqueous composition. The rise in pH should be at least 0.5 units, preferably at least 1.0 units and optimally at least 2 units on the pH acidity scale. Ordinarily the pH of the first substance will range from about 1 to about 4, preferably from about 2 to about 3.6. The second substance will have a pH
ranging from about 7 to about 11, preferably from about 8 to about 9. When the first and second substances are combined, the blend should have a pH ranging from about 4.5 to about 6.5.
Among the most suitable alkaline materials are the bicarbonate salts, especially sodium and potassium bicarbonates. These may be present in the aqueous composition in an amount from about 1 to about 30%, preferably from about 1.5 to about 10%, optimally between about 2 and 5% by weight of the aqueous composition.
Alkaline materials stronger than bicarbonate may also be present. These include ammonia, alkylamines, hydroxyalkylamines and alkanolamines. Examples of these are triethylamine, triethanolamine, diethanolamine, tetra(hydroxypropyl) diamine, 2-amino-2-methylpropan-1-ol, 2-amino-2-ethyl-1,3-propanediol and 2-amino-2-hydroxymethyl-1,3-propanediol. Levels of the organic alkaline subslance `
GUERRERO ET AL. 92-031 0-EA
may range from about 0.1 to 10%, preferably from about 0.5 to about 5%, optimally between about 0.8 and 1.5% by weight of the aqueous composition.
As a carrier, the aqueous composition will of course include a major amount of water. This amount may range from about 40% to about 99%, preferably between about 60 and about 95%, optimally between about 80 and 85% by weight of the aqueous composition.
Supplemental carriers may include monohydric and polyhydric alcohols ranging in amounts about 1 to about 30%, especially from about 3 and 20%, optimally between about 4 and 15% by weight of the aqueous composition. Especially preferred are ethanol, isopropanol, ethylene glycol, propylene glycol and butylene glycol.
Thickeners or viscosifiers may be present in amounts up to about 10% by weight. As known to those skilled in the art, the precise amount of thickeners can vary depending upon the desired consistency and thickness of the composition.
Exemplary thickeners are xanthan gum, sodium carboxymethyl cellulose, hydroxyalkyl and alkyl celluloses, and cross-linked acrylic acid polymers such as those sold by B.F.
Goodrich under the Carbopol trademark. Most preferred is methyl cellulose and hydroxypropyl methyl cellulose at levels from 0.1 to 5%, preferably from about 0.2 to GUERRERO ET AL. 92-0310-EA
1%, optimally about 0.5% by weight of the aqueous composition.
Preservatives can desirably be incorporated into the cosmetic compositions of this invention to protect against the growth of potentially harmful microorganisms.
While it is in the aqueous phase that microorganisms tend to grow, microorganisms can also reside in the anhydrous or oil phase. As such-, preservatives which have solubility in both water and oil are preferably employed in the present compositions.
Suitable traditional preservatives for compositions of this invention are alkyl esters of parahydroxybenzoic acid. Other preservatives which have more recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds. Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability. Particularly preferred preservatives are methylparaben, imidazolidinyl urea, sodium dehydroacetate, propylparaben, trisodium ethylenediamine tetraacetate (EDTA) and benzyl alcohol. The preservative should be selected having regard for possible incompatibilities between the preservative and other ingredients.
Preservatives are preferably employed in amounts ranging from about 0.01% to about 2% by weight of the composition.
Minor adjunct ingredients may also include fragrances, antifoam agents, 2143S2~
GUERRERO ET AL. 92-031 0-EA
opacifiers (e.g. titanium dioxide) and colorants, each in their effective amounts to accomplish their respective functions. Particularly useful minor ingredients are vitamin E linoleate, sodium hyaluronate and aloe vera gel, as well as other botanicals.
A sunscreen agent is a further desirable ingredient of the compositions of this invention. This ingredient is preferably incorporated into the aqueous composition.
The term Hsunscreen agent" as used herein defines ultraviolet ray-blocking compounds exhibiting absorption within the wavelength region between 290 and 400 nm.
Sunscreens may be classified into five groups based upon their chemical structure:
para-amino benzoates; salicylates; cinnamates; benzophenones; and miscellaneous chemicals including menthyl anthranilate and digalloyl trioleate. Inorganic sunscreens may also be used including titanium dioxide, zinc oxide, iron oxide and polymer particles such as those of polyethylene, polymethylmethacrylates and polyamides.
Preferred materials include p-aminobenzoic acid and its derivatives, anthranilates;
salicylates; cinnamates; coumarin derivatives; azoles; and tannic acid and its derivatives.
According to the present invention there is required a multi-compartment dispenser. Illustrative of such dispensers are those disclosed in U.S. Patents 1,639,699 and 1,699,532, each to Hopkins, describing double collapsible tubes.
` 2143523 GUERRERO ET AL. 92~310-EA
Separation of reactive components is also described in U.S. Patent 4,211,341 (Weyn). Other examples are those found in U.S. Patent 4,487,757 (Kiozpeoplou) under Fig. 1 as well as U.S. Patent 4,528,180, U.S Patent 4,687,663 and U.S. Patent 4,849,213, each of which is to Schaeffer.
The term ~multi-compartmentU may also include separation by means of encapsulation. Thus, the aqueous composition may contain microcapsules surrounding the ascorbic acid composition, the capsule walls serving as a separating compartment. Release of ascorbic acid occurs by crushing of the capsule walls as the product is rubbed onto the skin.
For purposes of this invention, the weight ratio of the aqueous to nonaqueous composition may range from about 10:1 to 1:10, preferably 2:1 to 1:2, optimally about 1:1.
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise indicated.
21~3523 GUERRERO ET AL. 92-0310-EA
An aqueous and an anhydrous composition were prepared according to the formulations set forth below. Each of the compositions were then charged to a respective separate compartment of a dual compartment dispensing apparatus. Each of the compositions had the following components:
COMPOSITION A
Aqueous CompositionWt. %
Deionized Water 83.0 Ethyl Alcohol 7.5 Butylene Glycol 5.0 Sodium Bicarbonate 3.0 Triethanolamine 1.0 Methocel 40-101 (Hydroxypropylmethyl cellulose) 0.5 -GUERRERO ET AL. 92-031 0-EA
COMPOSITION B
Anhydrous Composition Wt. %
Carbowax 400 (polyethylene glycol) 84.0 Ascorbic Acid (Vitamin C) 5.0 Ethyl Alcohol 5.0 Anhydrous Citric Acid 3.0 Isostearic Acid 3.0 21~3~23 GUERRERO ET AL. 92-0310-EA
An aqueous and an anhydrous composition according to the present invention are set forth below. Each of the compositions is charged to a respective separate compartment of a dual-compartment dispensing apparatus. The compositions includethe following components:
COMPOSITION A
Aqueous Composition Wt. %
Deionized Water 77.0 Ethyl Alcohol 8.0 Butylene Glycol 6.0 Triethanolamine 4.0 Dimethicone Copolyol 4.0 Eusolex 232 (sunscreen) 0.5 Methyl Cellulose 0.5 21435~3 -GUERRERO ET AL. 92-031 0-EA
COMPOSITION B
Anhydrous Composition Wt. %
Glycerin 82.0 Ascorbic Acid (Vitamin C) 5.0 Ethyl Alcohol 5.0 Anhydrous Glycolic Acid 3.0 Isostearic Acid 3.0 Dimethicone 2.0 GUERRERO ET AL. 92-0310-EA
An aqueous and an anhydrous composition according to the present invention are set forth below. Each of the compositions is charged to a respective separate compartment of a dual-compartment dispensing apparatus. The compositions include the following components:
COMPOSITION A
Aqueous Composition Wt. %
Deionized Water 83.7 Propylene Glycol 8.0 Isopropanol 3.0 2-Amino-2-methylpropan-1-ol 3.0 Dimethicone Copolyol 2.0 Hydroxypropyl Methyl Cellulose 0.3 ` 2143S23 -GUERRERO ET AL. 92-031 0-EA
COMPOSITION B
Anhydrous Composition Wt. %
Glycereth-7 83.0 Ascorbic Acid (Vitamin C) 5.0 Glycerin 5.0 Anhydrous Lactic Acid 3.0 Linolenic Acid 2.0 Dimethicone Copolyol 2.0 2143~23 GUERRERO ET AL. 92-031 0-EA
An aqueous and an anhydrous composition according to the present invention is set forth below. Each of the compositions is charged to a respective separate compartment of a dual-compartment dispensing apparatus. The compositions include the following components:
COMPOSITION A
Aqueous Composition ' Wt. %
Deionized Water 80.7 Propylene Glycol 8.0 Ethyl Alcohol 6.5 Triethanolamine 4.0 Eusolex 232 (sunscreen) 0.5 Sodium Carboxymethyl Cellulose 0.3 21~352~
' GUERRERO ET AL. 92-031 0-EA
COMPOSITION B
Anhydrous Composition Wt,%
Diethylene Glycol Monoethyl Ether 76.0 Ascorbic Acid (Vitamin C) 10.0 Ethyl Alcohol 5.0 Anhydrous Malic Acid 3.0 Oleic Acid 3.0 Polyoxyethylene 15 Trimethylolpropane Isostearate 3.0 GUERRERO ET AL. 92-031 0-EA
An aqueous and an anhydrous composition according to the present invention are set forth below. Each of the compositions is charged to a respective separate compartment of a dual-compartment dispensing apparatus. The compositions include the following components:
COMPOSITION A
Aqueous Composition ~ Wt. %
Deionized Water 83.0 Ethyl Alcohol 5.0 Butylene Glycol 5.0 Ammonium Hydroxide 4.0 Dimethicone Copolyol 2.5 Methyl Cellulose 0.5 214352~
-GUERRERO ET AL. 92-0310-EA
COMPOSITION B
Anhydrous Composition Wt.%
Carbowax 400 80.9 Isostearic Acid 7.0 Ascorbic Acid (Vitamin C) 5.0 Ethyl Alcohol 5.0 Polyoxyethylene 15 Trimethylolpropane Isostearate 2.0 Anhydrous Citric Acid 0.1 The foregoing description and examples illustrate selected embodiments of the present invention and in light thereof variations and modifications will be suggested to one skilled in the art, all of which are in the spirit and purview of this invention.
Claims (11)
1. A cosmetic product which is formed as a multi-compartment dispenser, wherein a first and second substance are stored apart from one another in separate compartments of the dispenser:
(i) the first substance being an anhydrous composition comprising from:
a) from 0.001 to 50% by weight of ascorbic acid; and b) from 0.01 to 99% by weight of a pharmaceutically acceptable carrier;
and (ii) the second substance being an aqueous composition comprising analkaline agent present in an effective amount to cause a rise in pH of the firstsubstance when blended therewith.
(i) the first substance being an anhydrous composition comprising from:
a) from 0.001 to 50% by weight of ascorbic acid; and b) from 0.01 to 99% by weight of a pharmaceutically acceptable carrier;
and (ii) the second substance being an aqueous composition comprising analkaline agent present in an effective amount to cause a rise in pH of the firstsubstance when blended therewith.
2. The cosmetic product according to claim 1 wherein the ascorbic acid is present in an amount from about 1 to about 10% by weight of the first substance.
3. The cosmetic product according to claim 1 wherein the anhydrous composition further comprises an acidifying agent present in an amount from about 0.1 to about 20% by weight thereof.
4. The cosmetic product according to claim 1 wherein the carrier is selected from the group consisting of glycerin, polyethylene glycol, polypropylene glycol, ethylene oxide/propylene oxide copolymers, alkoxylated polysaccharides, alkoxylated glycerol, monoalkyl glycol ether and mixtures thereof.
5. The cosmetic product according to claim 1 wherein the second substance includes a solvent selected from the group consisting of monohydric and polyhydric alcohols.
6. The cosmetic product according to claim 1 wherein the aqueous composition comprises an alkaline agent which is a bicarbonate salt.
7. The cosmetic product according to claim 1 wherein the aqueous composition comprises an alkaline agent selected from the group consisting of ammonia, alkylamine, hydroxyalkylamine and alkanolamine.
8. The cosmetic product according to claim 1 wherein the aqueous composition comprises from about 60 to about 95% water by weight thereof.
9. The cosmetic product according to claim 1 wherein the rise in pH is at least 0.5 units.
10. The cosmetic product according to claim 1 wherein the rise in pH is at least 2 units.
11. The cosmetic product as claimed in claim 1 and substantially as described herein.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002143523A CA2143523A1 (en) | 1995-02-27 | 1995-02-27 | Vitamin c delivery system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002143523A CA2143523A1 (en) | 1995-02-27 | 1995-02-27 | Vitamin c delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2143523A1 true CA2143523A1 (en) | 1996-08-28 |
Family
ID=4155324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002143523A Abandoned CA2143523A1 (en) | 1995-02-27 | 1995-02-27 | Vitamin c delivery system |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2143523A1 (en) |
-
1995
- 1995-02-27 CA CA002143523A patent/CA2143523A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5935584A (en) | Vitamin C delivery system | |
US5455035A (en) | Clear two-phase cosmetic composition | |
EP0910336B1 (en) | Vitamin c delivery system | |
AU656272B2 (en) | Self-tanner cosmetic composition | |
US5306486A (en) | Cosmetic sunscreen composition containing green tea and a sunscreen | |
US5162378A (en) | Silicone containing water-in-oil microemulsions having increased salt content | |
US5232688A (en) | Self-tanner cosmetic compositions | |
CA2084963C (en) | Self-tanner cosmetic composition | |
US5902591A (en) | Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid | |
US5618850A (en) | Hydroxy-acid cosmetics | |
US5008100A (en) | Oil-in-water emulsions containing polyethylene | |
CZ132998A3 (en) | Micro-structured cosmetic composition and process for preparing thereof | |
WO1998000103A1 (en) | Vitamin c delivery system | |
US5425939A (en) | Thickened cosmetic compositions | |
EP0729746A1 (en) | Vitamin C delivery system | |
JPH04338312A (en) | Cationic composition for skin | |
US6569414B1 (en) | Hair conditioners for treating split ends | |
US5807561A (en) | Emulsifying system for a whitening cosmetic composition | |
EP0729741A1 (en) | Clear two-phase cosmetic composition | |
CA2143523A1 (en) | Vitamin c delivery system | |
NZ270577A (en) | Cosmetic product where two reactive components (one being ascorbic acid) are stored separately in a multi-compartment dispenser until used | |
EP0729745A1 (en) | Vitamin C delivery system | |
JPH08245336A (en) | Vitamin c delivery system | |
NZ270576A (en) | Cosmetic product where two reactive components are stored separately in a multi-compartment dispenser until used | |
CA2143521A1 (en) | Clear two-phase cosmetic composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |